Alzinova Participated in GU Ventures’ Roundtable Discussion at the DI Impact Summit
Date: 2021-06-30
”We felt it was important to participate in GU Ventures' roundtable discussion at the DI Impact Summit since good health and well-being is one of the UN's 17 global sustainability development goals."
“Our goal is to enable patients suffering from Alzheimer’s disease to live an independent and active life by developing disease-modifying therapies that target with high precision the toxic amyloid beta oligomers involved in the onset and progression of Alzheimer’s disease.” Kristina Torfgård, our CEO,
Click the link below to read more and to see a recording of the roundtable session (in Swedish).